Plasma sLOX-1 is a potent biomarker of clinical remission and disease activity in patients with seropositive RA.

Abstract

OBJECTIVES Soluble lectin-like oxidized low-density lipoprotein receptor 1 (sLOX-1) is present in the circulation and synovial fluid in patients with rheumatoid arthritis (RA). The aim of this study was to assess whether sLOX-1 level is associated with clinical remission and disease activity in patients with RA. METHODS Clinical and laboratory data were… (More)
DOI: 10.3109/14397595.2015.1128871

Topics

  • Presentations referencing similar topics